Early Start of Infliximab in Crohn’s Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort

BACKGROUND: Over 10 years ago, the step-up/top-down trial demonstrated favorable outcomes of Crohn’s disease (CD) after early initiation of infliximab (IFX) in patients with CD. However, data on long-term effects of this treatment strategy in daily clinical practice are scarce. METHODS: This retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnitzler, Fabian, Seitz, Theresia, Tillack-Schreiber, Cornelia, Lange, Silke, Waggershauser, Constanze, Ochsenkühn, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802408/
https://www.ncbi.nlm.nih.gov/pubmed/36776655
http://dx.doi.org/10.1093/crocol/otab060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802408/
https://www.ncbi.nlm.nih.gov/pubmed/36776655
http://dx.doi.org/10.1093/crocol/otab060

Ejemplares similares